Articles

Toyota Motor’s shares rose sharply to a record high, extending the previous day’s gains after the automaker raised its fiscal-year earnings forecast.

Snap Inc.’s disappointing quarterly results and forecast, combined with one repeated excuse, don’t add up when compared to stronger results from other companies also reliant on internet ads, like Meta Platforms and Alphabet.

E.L.F. Beauty Inc. on Tuesday raised its full-year sales and profit outlook and said it had gained market share in its fiscal third quarter — a trend it said it could accelerate in the years ahead via a bigger push into retailers with its lower-priced cosmetics and skincare products.

The president of the Philadelphia Federal Reserve said inflation is slowing toward low, pre-pandemic levels and that the central bank appears primed to achieve a “soft landing” for the U.S. economy.

Even the wealthy have concerns: “It’s about the big emotions around major life decisions.”

Shares of companies that fell the most in Fortune’s “Most Admired” ranking outperformed the stocks of companies moving up the list.

Shares of Yum China Holdings Inc. rallied after hours on Tuesday after the company, which runs KFC and Pizza Hut restaurants in China, said it planned to “significantly accelerate” shareholder returns this year, even as other restaurants warn of weakening demand in that country.

Enphase Energy Inc. shares jumped after the alternative-energy company presented investors with a mixed quarter, but one that soothed more immediate concerns about the ailing sector.

The as-yet unnamed service, which could be available as early as the fall and offer a sort of Hulu for sports, comes amid an explosion in sports-streaming rights and audiences.

Consumer demand and higher prices on the menu outweighed higher ingredient costs.

After whiffing with its prior two earnings reports, Fortinet delivered upbeat profit and billings numbers for the latest quarter.

Amgen on Tuesday reported fourth quarter profits and sales that topped analyst expectations even as revenues dropped for one of its top-selling drugs.